Alzheimer's disease heterogeneity and co-pathologies: Defining novel targets, biomarkers, modalities, and research methodologies

Authors

• Malú Gámez Tansey, Indiana University
• Jorge J Llibre-Guerra, Washington University School of Medicine in St. Louis
• Suzanne E Schindler, Washington University School of Medicine in St. Louis

Journal

Alzheimer's & dementia : translational research & clinical interventions

Publication Date

1-1-2026

Volume

12

Issue

3

First Page

e70287

Document Type

Open Access Publication

DOI

10.1002/trc2.70287

Rights and Permissions

Tansey MG, Bozeat S, Ackerman P, et al. Alzheimer's disease heterogeneity and co-pathologies: Defining novel targets, biomarkers, modalities, and research methodologies. Alzheimer's Dement. 2026; 12:e70287. https://doi.org/10.1002/trc2.70287 © 2026 The Author(s). Alzheimer’s & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals LLC on behalf of Alzheimer’s Association. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Recommended Citation

Tansey, Malú Gámez; Llibre-Guerra, Jorge J; and Schindler, Suzanne E, "Alzheimer's disease heterogeneity and co-pathologies: Defining novel targets, biomarkers, modalities, and research methodologies." Alzheimer's & dementia : translational research & clinical interventions. 12, 3. e70287 (2026).
https://digitalcommons.wustl.edu/oa_4/7636

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.